May 4, 2011 – The most recent release of Via Oncology Pathways from D3 Oncology Solutions now includes decision support for advance care planning to encourage early discussions between oncologists and their patients about the disease, treatment intent and likely outcomes.

Recent articles on appropriate palliation and hospice have demonstrated positive effect that attention to planning end of life care can offer. One such study in oncology, a New England Journal of Medicine article by Temel JS et al, demonstrated over two months survival benefit to patients receiving less aggressive care in combination with symptom palliation in advanced non-small-cell lung cancer.

Advance care planning can be an increasingly difficult conversation for physicians, patients and family members as the disease progresses, balancing the benefit of continued aggressive treatment with a realistic appraisal of the benefit. Via Oncology Pathways raises the topic of advance care planning early in the process before treatments begin to ensure the patient has the best chance to make well-informed and thoughtful decisions.

The addition of the advance-planning feature prompts the oncologist to record whether the intent of a patient's treatment was curative or non-curative, and whether that intent was discussed with the patient. Additionally, for all patients with late stage disease, hospice or palliative care is prioritized as a pathway consideration each time the physician sees the patient. The oncologist, however, always maintains control with respect to when and how to broach the conversation with a patient make choices for end-of-life care.

Currently, D3's Via Oncology Pathways cover more than 85 percent of cancer diagnoses and include chemotherapy and biologics, radiation therapy, prognostic testing, supportive care treatments and advance care planning. All aspects of the pathways are delivered through a Web-based, patient-specific, point-of-care decision support tool that integrates into the practice's other information technologies. Additionally, advance care planning support is seamlessly built into the software to support the physician's workflow.

For more information: www.d3onc.com


Related Content

News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Artificial Intelligence

December 5, 2023 — Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro, the next-generation AI software for brain ...

Time December 05, 2023
arrow
News | Proton Therapy

July 5, 2023 — RaySearch Laboratories AB announced a strategic collaboration agreement with B dot Medical Inc. aimed at ...

Time July 05, 2023
arrow
News | Radiation Therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
Feature | AIMed | Christine Book

May 10, 2023 — The AiMed Global Summit will be held June 4-7, 2023, in San Diego, Calif, and program details offered ...

Time May 10, 2023
arrow
News | Radiation Oncology

February 20, 2023 — Varian, a Siemens Healthineers company, has entered into an agreement with Nova Scotia Health to ...

Time February 20, 2023
arrow
Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
Subscribe Now